For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240926:nRSZ8098Fa&default-theme=true
RNS Number : 8098F Braveheart Investment Group plc 26 September 2024
26 September 2024
Braveheart Investment Group plc
("Braveheart" the "Company" or the "Group")
Appointment of Braveheart representative to the Board of Autins Group plc
Braveheart Investment Group plc (AIM: BRH) announces that Dr Qu Li
(Non-Executive Director of Braveheart) has been appointed as a Non-Executive
Director to the Board of Autins Group plc ("Autins"). Braveheart holds 26.95%
per cent. of the issued share capital of Autins and Dr Qu Li has been
appointed to act as a representative of Braveheart on the Board of Autins.
As part of Dr Qu Li's appointment to the Board of Autins, Braveheart, Autins,
and the nominated adviser to Autins have all entered into a relationship
agreement (the "Relationship Agreement"). The Relationship Agreement is to
ensure that Autins is capable of carrying on its business independently of
Braveheart at all times, and that the costs associated with Qu Li's
appointment and tenure as a Director of Autins will be borne by Braveheart.
Trevor Brown, CEO of Braveheart, commented:
"It is three years since we first invested in Autins. Over the ensuing months,
as we got to know Autins and its Board, we became convinced that a bright
future lay ahead for the company as conditions in the global automative market
normalized after the shock of COVID. Qu Li has a deep knowledge of the sector
built over many years and we believe that her appointment will prove
beneficial to both Boards."
Braveheart Investment Group plc Tel: 01738 587555
Trevor Brown, Chief Executive Officer
Viv Hallam, Executive Director
Allenby Capital Limited (Nominated Adviser and Joint Broker) Tel: 020 3328 5656
James Reeve / George Payne
Peterhouse Capital Limited (Joint Broker) Tel: 020 7469 0936
Duncan Vasey / Lucy Williams
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAEAPNKADLLEEA